Characterization of persistent SARS-CoV infection in Vero E6 cells.
Mizutani
Tetsuya
T
National Institute of Infectious Diseases, Tokyo, Japan.
Fukushi
Shuetsu
S
Saijo
Masayuki
M
Kurane
Ichiro
I
D000085962:Angiotensin-Converting Enzyme 2; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D005786:Gene Expression Regulation; D006801:Humans; D048670:MAP Kinase Kinase 4 / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000096:biosynthesis; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D045473:Severe acute respiratory syndrome-related coronavirus / Q000378:metabolism*; D045169:Severe Acute Respiratory Syndrome / Q000821:virology*; D014709:Vero Cells; D051020:bcl-X Protein / Q000378:metabolism
D000085962:Angiotensin-Converting Enzyme 2; D048670:MAP Kinase Kinase 4; D007703:Peptidyl-Dipeptidase A; D019869:Phosphatidylinositol 3-Kinases; D051020:bcl-X Protein; C000705307:ACE2 protein, human